Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medic...(ing the medical marvel ofregenerative me...),Health
Navigation Links
Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
Date:3/17/2008
ing the medical marvel of regenerative medicine products to patients and to standardize their use in everyday medical care. For more information, visit http://www.organogenesis.com.
'/>"/>
| SOURCE Organogenesis, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
2. Take Care Health Systems Names Butler, Shine, Stern & Partners as First Marketing Agency of Record
3. Study names 5 factors of social ills in energy, mining and logging communities
4. Cardinal Health Names Michael C. Kaufmann to Lead Pharmaceutical Segment
5. Nellson Nutraceutical Names New Directors and Interim Chief Executive Officer
6. EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing
7. Independent Survey Names CyberKnife(R) System Most Widely Used Extracranial Radiosurgery Technology
8. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
9. Numira Biosciences Names New Board Member
10. Senior Lifestyle Corporation Names John Cobb as President and CEO
11. Women Health Care Executives Names Genomic Health President Kimberly Popovits as Woman of the Year
Post Your Comments:
Breaking Medicine News(10 mins):Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3Health News:Prostate Hormone Therapy May Up Heart Risks 2Health News:Prostate Hormone Therapy May Up Heart Risks 3Health News:New approach to sickle-cell disease shows promise in mice 2
[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans[0] Lilly Announces the First 300-unit Vial of Insulin[0] Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health[0] Prostate Hormone Therapy May Up Heart Risks[1] New approach to sickle-cell disease shows promise in mice
Other Medicine News:Health News:Prescription labels geared toward pharmacies, not patients 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 2Health News:New HIV diagnoses rising in New York City among young men who have sex with men 3Health News:New HIV diagnoses rising in New York City among young men who have sex with men 4Health News:Additional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management Software 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 2Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc. 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 2Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 3Health News:Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award 4Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 2Health News:New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users 3
Prescription labels geared toward pharmacies, not patientsNew HIV diagnoses rising in New York City among young men who have sex with menAdditional Top Tier Institutions Implement Mediware's HCLL(TM) Transfusion Management SoftwareCrystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS AwardNew Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
Breaking Medicine Technology:Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 1Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 2Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 3Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 4Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 5Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 6Reportlinker Adds Emerging Clinical Trial Locations India 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 62397 7Scientist Who Helps Explain Pain Wins Grawemeyer Award 62392 1Scientist Who Helps Explain Pain Wins Grawemeyer Award 62392 2Patient Safety Technologies Inc Appoints Marc L Rose CPA 28PA 29 Chief Financial Officer 6662 1Patient Safety Technologies Inc Appoints Marc L Rose CPA 28PA 29 Chief Financial Officer 6662 2
Other Medicine Technology:Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 2Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 3Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 2Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 3Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 4Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors 5
Adnexus Therapeutics Announces Presentation at the American,Association for Cancer Research (AACR) on Clinical Product,Candidate, CT-322Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC,Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with,Bruton's Tyrosine Kinase Inhibitors
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |